Li Yuan, Meng Qingtong, Luo Biru, Li Minlu, Fang Jinbo, Allred Sarah R, Fu Mei Rosemary
Department of Neonatology, West China Second University Hospital, Sichuan University, Chengdu, China.
Department of Nursing, West China Second University Hospital, Sichuan University, Chengdu, China.
Front Cardiovasc Med. 2023 Apr 11;10:1094805. doi: 10.3389/fcvm.2023.1094805. eCollection 2023.
Fluid overload remains a vexing problem in management of heart failure. The lymphatic system that plays the central role in fluid homeostasis has recently been explored as a potential target to counteract tissue fluid overload. The goal of the study was to evaluate the preliminary effects of exercises in activating lymphatic system on fluid overload symptoms, abnormal weight gains, and physical functions for patients with heart failure.
A pilot, pre- and post-test, randomized clinical trial was conducted to recruit a total of 66 patients who were randomized to receive either a 4-week The-Optimal-Lymph-Flow for Heart Failure (TOLF-HF) program or usual care alone. The primary outcome was the prevalence and burden of the fluid overload symptoms. Findings of the trial showed that the TOLF-HF intervention was effective in reducing the prevalence or burden of the majority of fluid overload symptoms. TOLF-HF intervention also demonstrated significant improvement in the outcomes of abnormal weight gains (MD: -0.82; 95% CI: -1.43 to -0.21; = 0.010) and physical functions ( = 13.792, < 0.001).
The TOLF-HF program focusing on activating lymphatic system through the performance of therapeutic lymphatic exercises holds the promise as an adjuvant therapy for patients with heart failure to manage fluid overload symptoms, reduce abnormal weight gains, and improve physical functions. Future larger-scale study with longer duration of follow-up is needed.
http://www.chictr.org.cn/index.aspx, identifier ChiCTR2000039121.
液体超负荷仍然是心力衰竭管理中一个棘手的问题。最近,在液体稳态中起核心作用的淋巴系统已被探索为对抗组织液体超负荷的潜在靶点。本研究的目的是评估运动激活淋巴系统对心力衰竭患者液体超负荷症状、异常体重增加和身体功能的初步影响。
进行了一项前瞻性、前后测试的随机临床试验,共招募66例患者,随机分为两组,分别接受为期4周的心力衰竭最佳淋巴引流(TOLF-HF)计划或单纯常规护理。主要结局是液体超负荷症状的发生率和负担。试验结果表明,TOLF-HF干预可有效降低大多数液体超负荷症状的发生率或负担。TOLF-HF干预还显著改善了异常体重增加(MD:-0.82;95%CI:-1.43至-0.21;P = 0.010)和身体功能(P = 13.792,P < 0.001)的结局。
通过进行治疗性淋巴运动来激活淋巴系统的TOLF-HF计划有望作为辅助治疗方法,用于心力衰竭患者管理液体超负荷症状、减少异常体重增加并改善身体功能。未来需要进行规模更大、随访时间更长的研究。